Nucleic acid therapies offer targeted treatment for genetic diseases, but delivery remains a key hurdle. Explore how advances ...

The research identifies microbial proteins, derived from bacteria, fungi, yeast, and algae, as a viable solution to this ...

Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

As the global food and health industries rapidly evolve, driven by consumer demand for healthier, more natural, and functional products, the search for innovative ingredients and reliable suppliers ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Eyam Health and Switzerland-based Medicines for Malaria Venture (MMV) announced a strategic research partnership to discover ...

An international team of fisheries scientists studying data gathered during the oceanic winter of 2022 in the Northeast ...

A research team from National Taiwan University, Academia Sinica, and National Taiwan University Hospital has uncovered a ...

Children with hematologic malignancies continue to exhibit increased IPD risk despite an overall decline in pediatric IPD after the introduction of the PCV13 vaccine.

Current approaches in bioengineering are synthesized and methods for their implementation are suggested for the induction and modulation of trained immunity in the treatment of human diseases.

Scripps scientists show that ribose may have been nature’s preferred sugar for building RNA, offering new insight into how life’s molecular foundations may have formed before biology began. Today, ...